Interactions of the apolipoprotein A5 gene polymorphisms and alcohol consumption on serum lipid levels

PLoS ONE

Volumn 6, Issue 3, 2011, Pages

  Yin, Rui Xing ^a   Li, Yi Yang ^a,b   Liu, Wan Ying ^a   Zhang, Lin ^a   Wu, Jin Zhen ^a  

^a FIRST AFFILIATED HOSPITAL OF GUANGXI MEDICAL UNIVERSITY   (China)

^b Guangxi Minzu Hospital   (China)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN A5; APOLIPOPROTEIN B; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; APOA5 PROTEIN, HUMAN; APOLIPOPROTEIN A; LIPID;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; GENE CLUSTER; GENE FREQUENCY; GENETIC POLYMORPHISM; GENOTYPE; HAPLOTYPE; HUMAN; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PROTEIN INTERACTION; SINGLE NUCLEOTIDE POLYMORPHISM; TRIACYLGLYCEROL BLOOD LEVEL; ADOLESCENT; AGED; BLOOD; DRINKING BEHAVIOR; ENVIRONMENT; GENETIC PREDISPOSITION; GENETICS; MIDDLE AGED; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ALCOHOL DRINKING; APOLIPOPROTEINS A; BASE SEQUENCE; DNA MUTATIONAL ANALYSIS; ENVIRONMENT; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; LIPIDS; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; POLYMORPHISM, GENETIC; YOUNG ADULT;

EID: 79952647265     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0017954     Document Type: Article

References (74)

1. Stamler J, Daviglus ML, Garside DB, Dyer AR, Greenland P, et al. (2000) Relationship of baseline serum cholesterol levels in 3 large cohorts of younger men to long-term coronary, cardiovascular, and all-cause mortality and to longevity. JAMA 284: 311-318.
2. Ruixing Y, Yuming C, Shangling P, Fengping H, Tangwei L, et al. (2006) Effects of demographic, dietary and other lifestyle factors on the prevalence of hyperlipidemia in Guangxi Hei Yi Zhuang and Han populations. Eur J Cardiovasc Prev Rehabil 13: 977-984.
3. Ruixing Y, Fengping H, Shangling P, Dezhai Y, Weixiong L, et al. (2006) Prevalence of hyperlipidemia and its risk factors for the middle-aged and elderly in the Guangxi Hei Yi Zhuang and Han populations. J Investig Med 54: 191-200.
4. Corella D, Tucker K, Lahoz C, Coltell O, Cupples LA, et al. (2001) Alcohol drinking determines the effect of the APOE locus on LDL-cholesterol concentrations in men: the Framingham Offspring Study. Am J Clin Nutr 73: 736-745.
5. Ruixing Y, Yiyang L, Meng L, Kela L, Xingjiang L, et al. (2010) Interactions of the apolipoprotein C-III 3238C>G polymorphism and alcohol consumption on serum triglyceride levels. Lipids Health Dis 9: 86.
6. Zhou Y, Yin R, Deng Y, Li Y, Wu J, (2008) Interactions between alcohol intake and the polymorphism of rs708272 on serum high-density lipoprotein cholesterol levels in the Guangxi Hei Yi Zhuang population. Alcohol 42: 583-591.
7. Doll R, Peto R, Hall E, Wheatley K, Gray R, (1994) Mortality in relation to consumption of alcohol. BMJ 309: 911-918.
8. Camargo CA Jr, Hennekens CH, Gaziano JM, Glynn RJ, Manson JE, et al. (1997) Prospective study of moderate alcohol consumption and mortality in US male physicians. Arch Intern Med 157: 79-85.
9. Choudhury SR, Ueshima H, Kita Y, Kobayashi KM, Okayama A, et al. (1994) Alcohol intake and serum lipids in a Japanese population. Int J Epidemiol 23: 940-947.
10. Silva ER, De Oliveira E, Foster D, McGee Harper M, Seidman CE, Smith JD, et al. (2000) Alcohol consumption raises HDL cholesterol levels by increasing the transport rate of apolipoproteins A-I and A-II. Circulation 102: 2347-2352.
11. Agarwal DP, (2002) Cardioprotective effects of light-moderate consumption of alcohol: a review of putative mechanisms. Alcohol Alcohol 37: 409-415.
12. Savolainen MJ, Kesaniemi YA, (1995) Effects of alcohol lipoproteins in relation to coronary heart disease. Curr Opin Lipidol 6: 243-250.
13. Stampfer MJ, Krauss RM, Ma J, Blanche PJ, Holl LG, et al. (1996) A prospective study of trigliceryde level, low-density lipoprotein particle diameter, and risk of myocardial infarction. JAMA 276: 882-888.
14. O'Brien PJ, Alborn WE, Sloan HJ, Ulmer M, Boodhoo A, et al. (2005) The novel apolipoprotein A5 is present in human serum, is associated with VLDL, HDL, and chylomicrons, and circulates at very low concentrations compared with other apolipoproteins. Clin Chem 51: 351-359.
15. Ishihara M, Kujiraoka T, Iwasaki T, Nagano M, Takano M, et al. (2005) A sandwich enzyme-linked immunosorbent assay for human plasma apolipoprotein A-V concentration. J Lipid Res 46: 2015-2022.
16. Pennacchio LA, Olivier M, Hubacek JA, Cohen JC, Cox DR, et al. (2001) An apolipoprotein influencing triglycerides in humans and mice revealed by comparative sequencing. Science 294: 169-173.
17. van der Vliet HN, Sammels MG, Leegwater AC, Levels JH, Reitsma PH, et al. (2001) Apolipoprotein A-V: a novel apolipoprotein associated with an early phase of liver regeneration. J Biol Chem 276: 44512-44520.
18. Endo K, Yanagi H, Araki J, Hirano C, Yamakawa-Kobayashi K, et al. (2002) Association found between the promoter region polymorphism in the apolipoprotein A-V gene and the serum triglyceride level in Japanese schoolchildren. Hum Genet 111: 570-572.
19. van der Vliet HN, Schaap FG, Levels JH, Ottenhoff R, Looije N, et al. (2002) Adenovirus overexpression of apolipoprotein A-V reduces serum levels of triglycerides and cholesterol in mice. Biochem Biophys Res Commun 295: 1156-1159.
20. Pennacchio LA, Olivier M, Hubacek JA, Krauss RM, Rubin EM, et al. (2001) Two independent apolipoprotein A5 haplotypes influence human plasma triglyceride levels. Hum Mol Genet 11: 3031-3038.
21. Nabika T, Nasreen S, Kobayashi S, Masuda J, (2002) The genetic effect of the apoprotein AV gene on the serum triglyceride level in Japanese. Atherosclerosis 165: 201-204.
22. Lai CQ, Tai ES, Tan CE, Cutter J, Chew SK, et al. (2003) The ApoA5 locus is a strong determinant of plasma triglyceride concentrations across ethnic groups in Singapore. J Lipid Res 44: 2365-2373.
23. Talmud PJ, Hawe E, Martin S, Olivier M, Miller GJ, et al. (2002) Relative contribution of variation within the APOC3/A4/A5 gene cluster in determining plasma triglycerides. Hum Mol Genet 11: 3039-3046.
24. Martin S, Nicaud V, Humphries SE, Talmud PJ, EARS Group (2003) Contribution of ApoA5 gene variants to plasma triglyceride determination and to the response to both fat and glucose tolerance challenges. Biochim Biophys Acta 1637: 217-225.
25. Seda O, Sedova L, (2003) New apolipoprotein A-V: comparative genomics meets metabolism. Physiol Res 52: 141-146.
26. Aouizerat BE, Kulkarni M, Heilbron D, Drown D, Raskin S, et al. (2003) Genetic analysis of a polymorphism in the human apoA-V gene: effect on plasma lipids. J Lipid Res 44: 1167-1173.
27. Baum L, Tomlinson B, Thomas GN, (2003) ApoA5 -1131T>C polymorphism is associated with triglyceride levels in Chinese men. Clin Genet 63: 377-379.
28. Masana L, Ribalta J, Salazar J, Fernandez-Ballart J, Joven J, et al. (2000) The apolipoprotein AV gene and diurnal triglyceridaemia in normolipidaemic subjects. Clin Chem Lab Med 41: 517-521.
29. Austin MA, Talmud PJ, Farin FM, Nickerson DA, Edwards KL, et al. (2004) Association of apolipoprotein A5 variants with LDL particle size and triglyceride in Japanese Americans. Biochim Biophys Acta 1688: 1-1689.
30. Evans D, Buchwald A, Beil FU, (2003) The single nucleotide polymorphism -1131T>C in the apolipoprotein A5 (ApoA5) gene is associated with elevated triglycerides in patients with hyperlipidemia. J Mol Med 81: 645-654.
31. Kao JT, Wen HC, Chien KL, Hsu HC, Lin SW, (2003) A novel genetic variant in the apolipoprotein A5 gene is associated with hypertriglyceridemia. Hum Mol Genet 12: 2533-2539.
32. Horinek A, Vrablik M, Ceska R, Adamkova V, Poledne R, et al. (2003) T-11313C polymorphism within the apolipoprotein AV gene in hypertriglyceridemic individuals. Atherosclerosis 167: 369-370.
33. Li GP, Wang JY, Yan SK, Chen BS, Xue H, et al. (2004) Genetic effect of two polymorphisms in the apolipoprotein A5 gene and apolipoprotein C3 gene on serum lipids and lipoproteins levels in a Chinese population. Clin Genet 65: 470-476.
34. Chaaba R, Attia N, Hammami S, Smaoui M, Mahjoub S, et al. (2005) Association of SNP3 polymorphism in the apolipoprotein A-V gene with plasma triglyceride level in Tunisian type 2 diabetes. Lipids Health Dis 4: 1.
35. Chen ES, Cendoroglo MS, Ramos LR, Araujo LM, Carvalheira GM, et al. (2006) APO A-V-1131T- ->C polymorphism frequency and its association with morbidity in a Brazilian elderly population. Clin Chem Lab Med 44: 32-36.
36. Moreno R, Perez-Jimenez F, Marin C, Moreno JA, Gomez P, et al. (2006) A single nucleotide polymorphism of the apolipoprotein A-V gene-1131T>C modulates postprandial lipoprotein metabolism. Atherosclerosis 189: 163-168.
37. Dallinga-Thie GM, van Tol A, Hattori H, van Vark-van der Zee LC, Jansen H, et al. (2006) Plasma apolipoprotein A5 and triglycerides in type 2 diabetes. Diabetologia 49: 1505-1511.
38. Havasi V, Szolnoki Z, Talián G, Bene J, Komlósi K, et al. (2006) Apolipoprotein A5 gene promoter region T-1131C polymorphism associates with elevated circulating triglyceride levels and confers susceptibility for development of ischemic stroke. J Mol Neurosci 29: 177-183.
39. Moreno-Luna R, Perez-Jimenez F, Marin C, Perez-Martinez P, Gomez P, et al. (2007) Two independent apolipoprotein A5 haplotypes modulate postprandial lipoprotein metabolism in a healthy Caucasian population. J Clin Endocrinol Metab 92: 2280-2285.
40. Hubacek JA, Bohuslavova R, Skodova Z, Pitha J, Bobkova D, et al. (2007) Polymorphisms in the APOA1/C3/A4/A5 gene cluster and cholesterol responsiveness to dietary change. Clin Chem Lab Med 45: 316-320.
41. Chien KL, Chen MF, Hsu HC, Su TC, Chang WT, et al. (2008) Genetic association study of APOA1/C3/A4/A5 gene cluster and haplotypes on triglyceride and HDL cholesterol in a community-based population. Clin Chim Acta 388: 78-83.
42. Chien KL, Fang WH, Wen HC, Lin HP, Lin YL, et al. (2008) APOA1/C3/A5 haplotype and risk of hypertriglyceridemia in Taiwanese. Clin Chim Acta 390: 56-62.
43. Huang MC, Wang TN, Wang HS, Sung YC, Ko YC, et al. (2008) The-1131T>C polymorphism in the apolipoprotein A5 gene is related to hypertriglyceridemia in Taiwanese aborigines. Kaohsiung J Med Sci 24: 171-179.
44. Kluger M, Heeren J, Merkel M, (2008) Apoprotein A-V: An important regulator of triglyceride metabolism. J Inherit Metab Dis 31: 281-288.
45. Talmud PJ, Martin S, Taskinen MR, Frick MH, Nieminen MS, et al. (2004) ApoA5 gene variants, lipoprotein particle distribution, and progression of coronary heart disease: results from the LOCAT study. J Lipid Res 45: 750-756.
46. Lai CQ, Demissie S, Cupples LA, Zhu Y, Adiconis X, et al. (2004) Influence of the APOA5 locus on plasma triglyceride, lipoprotein subclasses, and CVD risk in the Framingham Heart Study. J Lipid Res 45: 2096-2105.
47. Szalai C, Keszei M, Dubad J, Prohászka Z, Kozma GT, et al. (2004) Polymorphism in the promoter region of the apolipoprotein A5 gene is associated with an increased susceptibility for coronary artery disease. Atherosclerosis 173: 109-114.
48. Liu H, Zhang S, Lin J, Li H, Huang A, et al. (2005) Association between DNA variant sites in the apolipoprotein A5 gene and coronary heart disease in Chinese. Metabolism 54: 568-572.
49. Hsu LA, Ko YL, Chang CJ, Hu CF, Wu S, et al. (2006) Genetic variations of apolipoprotein A5 gene is associated with the risk of coronary artery disease among Chinese in Taiwan. Atherosclerosis 185: 143-149.
50. Tang Y, Sun P, Guo D, Ferro A, Ji Y, et al. (2006) A genetic variant c.553G > T in the apolipoprotein A5 gene is associated with an increased risk of coronary artery disease and altered triglyceride levels in a Chinese population. Atherosclerosis 185: 433-437.
51. Shanker J, Perumal G, Rao VS, Khadrinarasimhiah NB, John S, et al. (2008) Genetic studies on the APOA1-C3-A5 gene cluster in Asian Indians with premature coronary artery disease. Lipids Health Dis 7: 33.
52. Lee KWJ, Ayyobi AF, Frohlich JJ, Hill JS, (2004) APOA5 gene polymorphism modulates levels of triglyceride, HDL cholesterol and FERHDL but is not a risk factor for coronary artery disease. Atherosclerosis 176: 165-172.
53. Ribalta J, Figuera L, Fernandez-Ballart J, Vilella E, Castro Cabezas M, et al. (2002) Newly identified apolipoprotein AV gene predisposes to high plasma triglycerides in familial combined hyperlipidemia. Clin Chem 48: 1597-1600.
54. People's Republic of China-United States Cardiovascular and Cardiopulmonary Epidemiology Research Group (1992) An epidemiological study of cardiovascular and cardiopulmonary disease risk factors in four populations in the People's Republic of China. Baseline report from the P.R.C.-U.S.A. Collaborative Study. Circulation 85: 1083-1096.
55. Ruixing Y, Limei Y, Yuming C, Dezhai Y, Weixiong L, et al. (2006) Prevalence, awareness, treatment, control and risk factors of hypertension in the Guangxi Hei Yi Zhuang and Han populations. Hypertens Res 29: 423-432.
56. Ruixing Y, Hui L, Jinzhen W, Weixiong L, Dezhai Y, et al. (2009) Association of diet and lifestyle with blood pressure in the Guangxi Hei Yi Zhuang and Han populations. Public Health Nutr 12: 553-561.
57. Cooperative Meta-analysis Group of China Obesity Task Force (2002) Predictive values of body mass index and waist circumference to risk factors of related diseases in Chinese adult population. Chin J Epidemiol 23: 5-10.
58. Rimm EB, Williams P, Fosher K, Criqui M, Stampfer MJ, (1999) Moderate alcohol intake and lower risk of coronary heart disease: meta-analysis of effects on lipids and haemostatic factors. BMJ 319: 1523-1528.
59. Puddey IB, Croft KD, (1999) Alcohol, stroke and coronary heart disease. Are there anti-oxidants and pro-oxidants in alcoholic beverages that might influence the development of atherosclerotic cardiovascular disease? Neuroepidemiology 18: 292-302.
60. Yoon YS, Oh SW, Baik HW, Park HS, Kim WY, (2004) Alcohol consumption and the metabolic syndrome in Korean adults: the 1998 Korean National Health and Nutrition Examination Survey. Am J Clin Nutr 80: 217-224.
61. Hubácek JA, Adámková V, Ceska R, Poledne R, Horínek A, et al. (2004) New variants in the apolipoprotein AV gene in individuals with extreme triglyceride levels. Physiol Res 53: 225-228.
62. Hubacek JA, Adamkova V, Prusikova M, Snejdrlova M, Hirschfeldova K, et al. (2009) Impact of apolipoprotein A5 variants on statin treatment efficacy. Pharmacogenomics 10: 945-950.
63. Pennacchio LA, Rubin EM, (2003) Apolipoprotein A5, a newly identified gene that affects plasma triglyceride levels in humans and mice. Arterioscler Thromb Vasc Biol 23: 529-534.
64. Renaud S, de Lorgeril M, (1992) Wine, alcohol, platelets, and the French paradox for coronary heart disease. Lancet 339: 1523-1526.
65. Wannamethee SG, Shaper AG, (1999) Type of alcoholic drink and risk of major coronary heart disease events and all-cause mortality. Am J Public Health 89: 685-690.
66. Grønbæk M, Becker U, Johansen D, Gottschau A, Schnohr P, et al. (2000) Type of alcohol consumed and mortality from all causes, coronary heart disease, and cancer. Ann Int med 133: 411-419.
67. Theobald H, Bygren LO, Carstensen J, Engfeldt P, (2000) A moderate intake of wine is associated with reduced total mortality and reduced mortality from cardiovascular disease. J Stud Alcohol 61: 652-656.
68. Gaziano JM, Hennekens CH, Godfried SL, Sesso HD, Glynn RJ, et al. (1999) Type of alcoholic beverage and risk of myocardial infarction. Am J Cardiol 83: 52-57.
69. Koppes LL, Twisk JW, Van Mechelen W, Snel J, Kemper HC, (2005) Cross-sectional and longitudinal relationships between alcohol consumption and lipids, blood pressure and body weight indices. J Stud Alcohol 66: 713-721.
70. Volcik KA, Ballantyne CM, Fuchs FD, Sharrett AR, Boerwinkle E, (2008) Relationship of alcohol consumption and type of alcoholic beverage consumed with plasma lipid levels: differences between Whites and African Americans of the ARIC study. Ann Epidemiol 18: 101-107.
71. Ruidavets JB, Ducimetière P, Arveiler D, Amouyel P, Bingham A, et al. (2002) Types of alcoholic beverages and blood lipids in a French population. J Epidemiol Community Health 56: 24-28.
72. Parker DR, McPhillips JB, Derby CA, Gans KM, Lasater TM, et al. (1996) High-density-lipoprotein cholesterol and types of alcoholic beverages consumed among men and women. Am J Public Health 86: 1022-1027.
73. Humphries S, Talmud P, Monsalve V, McKeigue P, (1989) RFLP studies in different ethnic groups. Atherosclerosis 75: 249-250.
74. Yin R, Chen Y, Pan S, He F, Liu T, et al. (2006) Comparison of lipid levels, hyperlipidemia prevalence and its risk factors between Guangxi Hei Yi Zhuang and Han populations. Arch Med Res 37: 787-793.